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ABSTRACT
Nowadays, food and nutrition have a greater impact in people’s concerns, with the awareness that
nutrition have a direct impact in health and wellbeing. Probiotics have an important role in this topic and
consumers are starting to really understand their potential in health, leading to an increasing interest of
the companies to their commercial use in foods. However, there are several limitations to the use of
probiotics in foods and beverages, being one of them their efﬁciency (directly associated to their survival
rate) upon ingestion.
This work is focused in microencapsulation techniques that have been used to increase probiotics
efﬁciency. More speciﬁcally, this work reviews the most recent and relevant research about the production
and coating techniques of probiotic-loaded microcapsules, providing an insight in the effect of these
coatings in probiotics survival during the gastrointestinal phase.
This review shows that coatings with the better performances in probiotics protection, against the harsh
conditions of digestion, are chitosan, alginate, poly-L-lysine, and whey protein. Chitosan presented an
interesting performance in probiotics protection being able to maintain the initial concentration of viable
probiotics during a digestive test. The analyses of different works also showed that the utilization of
several coatings does not guarantee a better protection in comparison with monocoated microcapsules.
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Probiotics
Probiotics are live microorganisms, which when administered in
adequate amounts confer a health beneﬁt to the host (Food and
Agriculture Organization of the United Nations/World Health
Organization, 2001). Probiotics have functions that are able to
induce a positive effect on human health, such as: (a) the produc-
tion of substances that inhibit pathogen action, blocking patho-
genic bacterial cells adhesion sites, (b) the promotion of nutrient
competition and production, (c) the degradation of toxins and
toxin receptors, and (d) the modulation of immune responses
(Prakash et al., 2011). These functions will help in: the reduction
of the expression of some biomarkers responsible for colonic
cancer; the treatment and prevention of acute diarrhea in chil-
dren; the prevention of an initial attack of pouchitis, maintaining
remission of ulcerative colitis; the reduction of the symptoms in
persons suffering from functional abdominal pain; the improve-
ment of lactose digestion and reduction of symptoms related to
lactose intolerance; and the reduction of the risk of necrotizing
enterocolitis (Aureli et al., 2011; Sullivan and Nord, 2005).
Probiotics market and legislation
There is an increasing demand from consumers for healthy and
natural food products, namely functional food products, that
are able to provide not only the normal positive impact
expected from foods, but also providing consumers with a
pleasant, fortiﬁed food (Siro et al., 2008; Verbeke, 2005). Func-
tional compounds can be used for the development of a wide
range of functional food products, being beverages and bakery
products the leading products where these kind of compounds
have been used (Fig. 1).
Probiotics are one of the areas of food research and develop-
ment where more resources are invested. Probiotics’ world
market was estimated in $ 3.3 billion in 2015; in the last decade
more than 500 new probiotic products were introduced in
foods’ and beverages’markets (Markets and market 2015).
Despite all difﬁculties for the approval of food claims, a high
number of probiotics have been introduced in foods. Some
examples are L. casei shirota on Yakult and Dannon, L. reuteri
by Biogaia and L. acidophilus by Nestle (California Dairy
Research Fundation, 2015). In Europe, probiotics are approved
for use in foods but the European Commission (EC) did not
approve yet any claim about their potential health beneﬁts,
mostly based on the lack of sufﬁcient scientiﬁc evidence
(Binnendijk and Rijkers, 2013).
In the United States of America (USA), the Food and Drugs
Administration (FDA), divides the utilization of ingredients in
four different groups based on their intended utilization and
their function in the human body. These four groups are: (a) a
drug, a new drug or a biological product; (b) a dietary supple-
ment; (c) a food or food ingredient; and (d) a medical food
(Degnan, 2008). Despite all differences on approval of
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probiotics health claims between Europe and USA, their evalu-
ation of probiotics is similar when a claim is directly related to
the effect of probiotics in a disease, being mandatory in both
countries the approval by their regulatory institutions (EU,
2014; U.S. National Institute of Health, 2012).
However, there are some countries that have already
approved health claims on probiotics’ beneﬁts. Some of these
countries are Japan and Canada. Canada approved general
claims considering that microorganisms as Lactobacillus john-
sonii La 1, L. johnsonii Lj 1, L. johnsonii NCC 533, L. rhamno-
sus GG and Saccharomyces boulardii provide a healthy gut ﬂora
and contribute with health beneﬁts to the host. Canada also
approved some particular claims that refer the beneﬁts of L.
johnsonii in the combat of Helicobacter pylori infections. L.
rhamnosus GG and Saccharomyces boulardii were also recog-
nized with claims referring the beneﬁts of these organisms in
the managing of diseases as infectious diarrhea, antibiotic-asso-
ciated diarrhea and reducing the risk of antibiotic-associated
diarrhea (Canadian Food Inspection Agency, 2015; Hoffmann
et al., 2013).
In Switzerland some efforts have been made in the last years
regarding the recognition of probiotics health effects. In 2013
two probiotic health claims were accepted for L. plantarum
LP299V (Vifor SA) and Activia (Danone). In 2014, LC1 (Lacta-
lis) and Biﬁdobacterium lactis HN019 (Dupont) were also the
main focus of approved health claims in Switzerland (Switzer-
land Confederation, 2014). More recently, Yakult has also seen
its Lactobacillus casei shirota with a health claim approved by
Switzerland authorities. These claims are mainly focused on
health beneﬁts in the digestion regulation and reduction of resi-
dence time (Switzerland Confederation, 2014).
The high investment that has been done in the last years
shows that even with the resistance of some regulatory authori-
ties regarding the recognition of probiotics’ health effects, they
continue to be a food trend with an endless potential to explore.
The pressure on food legislators about that subject is increasing
as much as scientiﬁc favorable opinions of researchers and
institutions are published. However, considering the lack of
information about the microbiota and the high difﬁculty to
understand the inﬂuence of a probiotic in the human body, the
food regulators adopted a more sceptical approach. The need
of investment on trials capable to show, without doubts, the
effects of these organisms in speciﬁc diseases is needed and
should be done. While the general recognition of these micro-
organism as beneﬁcial forms for Human health was already
accomplished, the identiﬁcation of their speciﬁc effects should
be proved in order to approve health claims.
Probiotics encapsulation
According to Gilliland (1989), probiotics should survive during
the passage through the upper digestive tract in a large number,
to ensure the desired beneﬁcial effects in the host. The mini-
mum suggested concentration of viable cells to provide the ben-
eﬁts mentioned before ranges between 108 and 109 viable cells
per day/dose (Doleyres and Lacroix, 2005; Hou et al., 2003).
Probiotics will act after colonization and growth on the intes-
tine and/or colon, being their survival mandatory, until they
reach their action spots (Albertini et al., 2010; Chandramouli
et al., 2004). Therefore, encapsulation is generally used to
improve probiotics survival during digestion, considering the
limitations of free probiotics survival (i.e., loss of viability due
to the acidic medium).
The main purpose of probiotics encapsulation is their pro-
tection against: high oxygen levels (Sunohara et al., 1995); food
processing (Tripathi and Giri, 2014); storage; and after con-
sumption (Azizi et al., 2010; Sousa et al., 2013), during the pas-
sage through the gastrointestinal system (Sun and Grifﬁths,
2000). Other advantages of probiotics encapsulation are the
prevention of their interfacial inactivation and the stimulation
of production and excretion of secondary metabolites (Nazzaro
et al., 2012).
Encapsulation methods
The incorporation of functional ingredients in foods is complex
and in some cases requires, besides the protection of their func-
tionality, the control of their release. Because of that, the encap-
sulation process chosen will have a very important role in the
incorporation of functional ingredients in food products
(Cerqueira et al., 2014; Ubbink and Kru, 2006). Microencapsu-
lation (ME) is the “technology of packing solids, liquids, and
gaseous materials in small capsules that release those contents
at controlled rates over long periods of time” (Champagne and
Fustier, 2007). This technology can be used to encapsulate pro-
biotics, however during the encapsulation process the viability
of the microorganisms should be maintained (Rathore et al.,
2013). This means that materials and methodologies used for
their production should be carefully evaluated. Other speciﬁca-
tion is the size of the capsules that some authors mention that
must be smaller than 100 mm to avoid a “gritty” sensation
when consumed (Hansen et al., 2002; Heidebach et al., 2012).
The mouthfeel sensation of capsules in food was evaluated by
sensorial analyses and results showed that small (2–30 mm),
soft and spherical capsules in a lower concentration added to a
high viscous gel produce a more pleasant sensation, instead of
large (71–70 mm), hard, or sharp capsules added in high con-
centrations to a low viscous medium, which produces a rough
and gritty sensation (Engelen et al., 2005; Imai et al., 1995).
Moreover, a recent study showed that capsules with an average
size of 30 mm are not detected by sensorial analysis (Heidebach
et al., 2012). The solubility of the capsules is an important
Figure 1. Functional food products on the European market in 2008 by sectors.
Adapted from Stein and Rodrıguez-Cerezo (2008).
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characteristic because microcapsules should be water-insoluble,
to maintain their structure when introduced in foods and bev-
erages, and during the passage through the gastrointestinal sys-
tem upper part (Ding and Shah, 2007; Picot and Lacroix, 2004)
and should be able to release the probiotics in the intestinal
track. In fact, microencapsulation technology implies a great
knowledge of the characteristics of the materials used (e.g.,
evaluation of the possible interactions between the functional
ingredient with the used material) (Augustin and Sanguansri,
2008), that should be food grade and approved by regulatory
authorities. Another issue is the methodology used for probiot-
ics encapsulation (e.g., extrusion, emulsion, and spray-drying)
that inﬂuences probiotics’ viability due the conditions used
(e.g., temperature). In the next section the most commonly
used techniques for probiotics encapsulation will be explained
in detail.
Table 1 lists the materials that have been used for encapsula-
tion of probiotics by extrusion, emulsiﬁcation and spray drying.
The main advantages of encapsulation by extrusion are the
simplicity of operation, good performance in a laboratorial
environment, lower cost, and high cell viability (Vos et al.,
2010). The disadvantages are: the impossibility to produce cap-
sules smaller than 500 mm and greater than 3 mm (Krasae-
koopt et al., 2003) by a conventional dropwise method, the
process duration and the difﬁculty of scale-up (Burgain et al.,
2011; Liu et al., 2002). To avoid these disadvantages variations
to this method were developed, such as the utilization of noz-
zles instead of syringe and needle, or the use of emulsions for
the production of the microcapsules. When the drop wise
method is based in spray systems, such as vibrating nozzles
(Chandramouli et al., 2004), air-atomizing nozzles (Cui et al.,
2000) and spinning-disk atomization (Senuma et al., 2000) it is
possible to produce capsules smaller than 500 mm. More infor-
mation about the materials used and the sizes and morpholo-
gies of the obtained capsules can be found in Rokka and
Rantamaki (2010).
Emulsiﬁcation main advantage is the possibility to create
capsules smaller than 100 mm, which is possible due to the
small size of the emulsion droplets created, which control the
ﬁnal size (ranged between 25 mm and 2 mm) of the capsules
(Heidebach et al., 2009; Mokarram et al., 2009a; Sheu and Mar-
shall, 1993). The main disadvantages are: (a) the yield of pro-
duced capsules that is very low considering the amount of
materials used, during the production (i.e., oil), brings a consid-
erable problem regarding waste, even at a laboratorial scale; (b)
microcapsules separation from the different phases that may
damage the capsules; and (c) the high size variation of the pro-
duced capsules. Other possible problems are the negative inﬂu-
ence of the high stirring rate, the need to form an emulsion,
which can inﬂuence the probiotics survival, and the impossibil-
ity to sterilize vegetable oil if a strict asepsis is mandatory
(Gbassi and Vandamme, 2012).
The main advantages of the spray drying method are the rel-
atively low cost of the process, the high production rate of cap-
sules and reproducibility (Burgain et al., 2011; Kailasapathy,
2002). Some of the disadvantages of this process lay on the fact
that the technique has a small ﬁeld of applications due to the
high temperatures used during the process. This fact can bring
some problems when the aim is the encapsulation of functional
compounds, such as probiotics (Burgain et al., 2011). The hot
air inlet temperature typically ranges between 150 and 220C,
which decreases during the solvent evaporation process to val-
ues between 50 and 80C (Gharsallaoui et al., 2007; Vos et al.,
2010). The exposure time of the functional compounds to these
high temperatures is of only a few seconds, and generally the
core of the microcapsules does not surpass 100C; however
these conditions are still a problem for probiotics encapsula-
tion, decreasing their viability (Estevinho et al., 2013; Lian
et al., 2002; Rokka and Rantam€aki, 2010).
The three encapsulation techniques mentioned above have
unique and speciﬁc characteristics that suit the encapsulation
of probiotics. The extrusion method presents a huge diversity
of machines and industrial components able to be adapted to
create capsules from different mixtures of polymers and cross
linkers. Moreover, these industrial equipment are also able to
create capsules’ sizes that are not achievable with conventional
protocols at a laboratorial scale. The same happens with spray
drying, which also presents a great ﬂexibility, although the pro-
cess temperature is still a huge drawback. At laboratory scale
emulsiﬁcation is clearly one of the most used encapsulation
techniques capable of producing capsules smaller than 100 mm,
however more studies and investment are needed for the utili-
zation of this technique at large scale.
Microcapsules coating techniques
Probiotics are usually encapsulated to be used in food, although
the current encapsulation techniques (i.e., extrusion, emulsiﬁ-
cation and spray-drying) are in some cases inefﬁcient regarding
the protection of microorganisms, thus decreasing their
Table 1. Polymers used for probiotics encapsulation by extrusion, emulsiﬁcation
and spray drying.
Material References
Extrusion
Sodium alginate (Etchepare et al., 2016; Smidsrd and
Skjak-Brae, 1990)
k-Carrageenan (B€uy€ukg€ung€or, 1992; Tsen et al., 2008)
Xanthan gum (Jimenez-Pranteda et al., 2012;
McMaster and Kokott, 2005)
Gellan (Jimenez-Pranteda et al., 2012)
Whey protein (Doherty et al., 2011; Guerin et al.,
2003)
Emulsiﬁcation
Sodium alginate (Holkem et al., 2016; Sheu and Marshall,
1993)
k-Carrageenan (Adhikari et al., 2003, 2000)
Chitosan (Groboillot et al., 1993; Peniche et al.,
2003)
Gelatine (Hyndman et al., 1993)
Caseinate (Crittenden et al., 2006; W€urth et al.,
2015)
Sesame oil (Hou et al., 2003)
Spray drying
Sodium alginate and Carrageenan (Burey et al., 2009)
Starch, Arabic gum, Gelatine, Whey
protein, Pea protein, and
Maltodextrin
(Arslan et al., 2015; Pinto et al., 2015)
Skim milk (Gardiner et al., 2002; Maciel et al.,
2014)
Fructooligosacharide (Rajam and Anandharamakrishnan,
2015)
Cellulose acetate phthalate (Antunes et al., 2013)
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viability (Rokka and Rantam€aki, 2010; Solanki et al., 2013).
Alginate is one of the most used materials for microencapsula-
tion, however alginate-based capsules have porous networks,
which allow the exposure of probiotics to the external medium,
that is a disadvantage regarding the protection of probiotics in
the stomach (Allan-Wojtas et al., 2008). Some works mention
that alginate microcapsules, without the application of a coat-
ing, have the capacity to protect probiotics during food storage,
but not upon the exposure to low pH solutions, such as in the
gastrointestinal conditions (Hansen et al., 2002; Sultana et al.,
2000). Another problem is the inﬂuence of microcapsules’ size
on probiotic protection, Heidebach and co-workers (2012) refer
that only capsules with sizes between 0.2 and 3 mm are able to
protect probiotics against gastrointestinal harsh conditions.
Considering this and that capsules with sizes smaller than
100 mm are preferable regarding sensory aspects, obviously
other solutions should be implemented to overcome these
limitations.
One of the solutions to improve the performance of
microcapsules is the application of a coating on microcap-
sules surface. This can be done using different materials,
which in some cases can be the same material used for
capsules production (Krasaekoopt et al., 2003). These coat-
ings will interact with the capsule’s surface creating an
additional membrane (layer) on the microcapsule (Heide-
bach et al., 2012) that will improve their performance con-
sidering probiotics protection. This coating will decrease
capsule’s permeability reducing the exposure of probiotics
to oxygen, during storage, and improve their stability at
low pH and high temperatures (Corona-Hernandez et al.,
2013; Heidebach et al., 2012; Mokarram et al., 2009a). In
other cases, these coatings were also used to give a new
function to the microcapsule, as adhesion properties or to
guarantee a controlled release of a micronutrient (Borges
and Mano, 2014; Tang et al., 2006).
Considering the protection of probiotics against the harsh
conditions of the gastrointestinal system, a huge variety and
combination of coating materials have been used. Different
techniques have been used to apply these coatings on probiotics
microcapsules, namely layer-by-layer assembly (LbL), per-
formed by the immersion of microcapsules in the polymer
solution that will lead to the formation of the coating, and coac-
ervation, where a coacervate is created between microcapsules’
surface and a polymer coating.
Layer-by-layer (LbL)
Layer-by-layer technique was ﬁrst used in the end of the twenti-
eth century to create multilayered ﬁlms, by the deposition of
ﬁlms in solutions with opposite charges (Decher, 1997; Decher
et al., 1992). This technique is based on the layer-by-layer
(LbL) principle where two main types of interactions are possi-
ble: hydrogen bonding or electrostatic interactions (Fou and
Rubner, 1995; Lvov et al., 1995; Sukhishvili and Granick, 2002).
LbL is the consecutive adhesion of different materials in a sur-
face, achieved by the consequent assemble of materials with the
opposite charge of the surface (Tang et al., 2006). This tech-
nique is based on the chemical electrostatic attraction of posi-
tively and negatively charged materials (Bertrand et al., 2000).
After its use on the production of multilayered ﬁlms, LbL tech-
nique started to be applied on other types of templates with dif-
ferent sizes (e.g., micro- and nanoscale), shapes (e.g., capsules)
and chemical compositions (Yan et al., 2014). One of the inter-
esting applications was performed by Champagne and co-
workers when they started to applied this technique in micro-
capsules with loaded probiotics (Champagne et al., 1992; Lar-
isch et al., 1994).
Presently LbL is the more common technique to create a
coating on a probiotic microcapsule where the simply immer-
sion of a microcapsule into a biopolymer solution will form a
protective coating (Heidebach et al., 2012). Figure 2 shows
more speciﬁcally this process where a microcapsule produced
by a cationic material (e.g., alginate) is consecutively coated by
an anionic material (e.g., poly-L-lysine) and after that by
another cationic material. The main forces involved on the uti-
lization of this technique, on probiotics-loaded microcapsules,
are electrostatic forces that will form a layer that will coat the
microcapsules (Borges and Mano, 2014). This electrostatic
interaction is possible through the utilization of negatively or
positively charged polymers or biopolymers. Many natural pol-
ysaccharides are made of monomers bearing charged groups
like amines, sulfates or carboxylic acids (Bertrand et al., 2000),
but those compounds must bear a minimal number of charged
Figure 2. Layer-by-layer technique scheme on probiotic microcapsules—a two-layers’ construction, where the original microcapsule is constituted by an anionic material.
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groups. For this, the pH control, concentration and ionic
strength of the polymer solution are fundamental to increase
the range between both charged materials that will increase the
interaction intensity (Carneiro-Da-Cunha et al., 2011).
An interesting feature of using this technique for the devel-
opment of a coating is the control of the layer’s thickness,
which has been studied in some works and shows no relevant
increase of capsules size. In microcapsules with approximately
280 mm a thickness ranging between 2 and 3 mm was reported
(Tam et al., 2005) and for microcapsules with approximately
40 mm a thickness of 40 nm was obtained (Lin et al., 2008).
Cook and co-workers showed that the thickness of a chitosan
coating on a alginate microcapsule increases with the immer-
sion time of the microcapsule in the chitosan solution, with a
minimal value of 8 mm, after 1 min, and a value of 24 mm, after
2400 min, on capsules with a diameter of approximately 1 mm
(2011). Other authors concluded that there were no differences
between the uncoated and coated microcapsules diameter (Koo
et al., 2001). There are several factors that could inﬂuence the
adhesion of materials during LbL, such as: pH, temperature,
ionic strength, adsorption time, polyelectrolyte molecular
weight, polyelectrolyte chain architecture, electrical ﬁeld, light,
mechanical stress, or the addition of other compounds such as
proteins or surfactants (Borges and Mano, 2014).
LbL is an easy, efﬁcient and reproducible method of modify-
ing surfaces of different structures (Borges and Mano, 2014).
This process is relatively cheap requiring mild conditions and
aqueous solutions during the process, working mainly with nat-
ural charged materials (Borges and Mano, 2014). Moreover, it
is versatile and reproducible, where adhesion times are between
1 and 60 minutes (Bertrand et al., 2000). The main disadvan-
tages of this method are related to the time of adhesion of each
layer, that it is not instantaneous (Borges and Mano, 2014).
Thus, during the adhesion of consecutive layers a total or par-
tial aggregation of the capsules may occur, which decreases the
available surface area for subsequent layer adhesions, decreas-
ing the process efﬁciency.
Coacervation
Coacervation has been used in microencapsulation of microbial
cells (Eratte et al., 2015; Hernandez-Rodrıguez et al., 2014;
Oliveira et al., 2007; Shoji et al., 2013; Zhu et al., 2013), but also
in the encapsulation of ﬂavors, preservatives and enzymes
(Park and Chang, 2000). A major drawback of coacervation
lays in the difﬁculty in obtaining capsules with small sizes
(Freitas et al., 2005; John et al., 2011) and because of that, less
emphasis has been given to coacervation techniques on the
production of probiotic-loaded microcapsules.
Coacervation is performed by mixing one or more incom-
patible polymers (simple or complex coacervation) with
another incompatible polymer, which will create a phase sepa-
ration at a speciﬁc pH, temperature or composition of the solu-
tion. On microcapsules’ coatings the polymers responsible for
the connection are the capsule’s surface polymer and the solu-
tion polymer. To promote the mixture between the two, or
more, polymers the dispersion is stirred. After this the parame-
ters mentioned before are changed leading to the separation of
incompatible polymer and deposition of the dense coacervate
phase surrounding the core material (probiotic microcapsule)
(Gouin, 2004). To separate the microcapsules, separation pro-
cesses such as centrifugation or ﬁltration can be used and the
encapsulated material can be also dried by spray or ﬂuidized
bed drying (Kailasapathy, 2009). To improve capsule’s resis-
tance it is possible to use chemical or enzymatic cross-linking
agents (Rathore et al., 2013). This technique has as the most
important processing factors the volume of the dispersed phase,
the addition rate of the incompatible polymer to the coating
polymer solution and the stirring rate of the dispersion (Nihant
et al., 1994). Some other factors, such as the composition and
viscosity of the coacervate and supernatant phases, can also
inﬂuence the size distribution, surface morphology and internal
porosity of the ﬁnal microspheres (Nihant et al., 1994).
Some limitations of this technique are related to the com-
plexity of the process, the control of different critical conditions
associated with composition and kinetics of reaction, the cost of
the process and in some speciﬁc cases the evaporation of the
core material, dissolution of the core in solvent and its possible
oxidation (Madene et al., 2006).
Materials for the coating of microcapsules
This section provides a description of the main materials used
on the coating of probiotic-loaded microcapsules and their per-
formance (Table 2). The main results regarding the comparison
of the uncoated and coated probiotic microcapsules in gastroin-
testinal simulation media will only be discussed in order to ana-
lyze if there is a positive or negative effect of the coating on the
probiotic survival in those media. Other works besides those
presented in Table 2 were also analyzed (see e.g., Fareez et al.,
2015; Garcıa-Ceja et al., 2015; Lee et al., 2004; Li et al., 2011;
Martoni et al., 2007; Mi et al., 2013a; Mokarram et al., 2009b;
Sohail et al., 2011; Zou et al., 2011).
Alginate
Alginate is a polysaccharide derived from brown algae or bacte-
rial sources constituted by 1!4 linked b-(D)-glucuronic (G)
and a-(L)-mannuronic (M) acids (Rinaudo, 2008). The main
reasons for its high utilization on probiotics microencapsula-
tion are its GRAS (generally regarded as safe) status being used
as a food additive worldwide, its lack of toxicity (Gombotz and
Wee, 1998), its strong capacity to be cross-linked and the dif-
ferent mild gelling characteristic which change with the molec-
ular weight and ratio between M and G acids (Thu et al., 1996).
Alginate, due to the presence of carboxylic groups on both
monomers, has a negative charge above its pKa (3.3–3.5)
(Cook et al., 2012), as presented in Fig. 3.
Furthermore, one of the characteristics that is interesting
regarding the creation of microcapsules is the high afﬁnity of
alginate residues to divalent metals, such as calcium, cadmium,
zinc and barium (Draget et al., 2000). With these interactions
an “egg-box” structure is formed, where happens the consecu-
tive connection of four alginate G residues to one metal ion,
which brings more stability and swelling capacity to the micro-
capsule, being the afﬁnity of these metals bigger with G residues
than with M residues (Thu et al., 1996). However, cations such
as sodium and magnesium have an anti-gelling inﬂuence in
alginate as they replace calcium in the matrix (Lee et al., 2004).
Equally, chelating agents such as phosphate can also contribute
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to the physical instability of the microcapsules by competing
with the matrix for the capture of calcium ions (Krasaekoopt
et al., 2006a). Other disadvantage of using alginate is its sensi-
tiveness to acidic media, being a concern when used to protect
bacteria against harsh stomach conditions (Burgain et al.,
2011). In some cases alginate is mixed with other polymers,
such as starch, to improve their resistance against acidic media
and thus increase their probiotic protection capacity (Hansen
et al., 2002; Krasaekoopt et al., 2003; Sultana et al., 2000; Sun
and Grifﬁths, 2000).
Alginate is not the most used material to coat probiotic-
loaded microcapsules, even though some works have presented
alginate with this functionality. Annan and co-workers pre-
sented an increased survival of 1.64 log CFU after the exposure
of Biﬁdobacterium adolescentis 15703T to gastric and intestinal
simulation media when experiments were performed with an
alginate coating, in comparison with an uncoated alginate
microcapsule (Anan et al., 2008). In other work, Krasaekoopt
et al. (2004) used the alginate coating on an alginate microcap-
sule and showed an increase of the bacteria survival on 5, 3,
and 3 log CFU (Lactobacillus acidophilus 547, Biﬁdobacterium
biﬁdum ATCC 1994, and Lactobacillus casei 01, respectively)
compared with the uncoated microcapsules. However, other
authors (Brinques and Ayub, 2011; Iyer and Kailasapathy,
2005) also showed that the utilization of alginate as a coating
did not have a relevant positive impact on bacteria’s survival.
Comparing the results above, it is clear that the effect of algi-
nate can be positive or not relevant, as a coating in different
works, considering probiotics protection. However, it is impor-
tant to understand in which situations an alginate coating can
have a positive impact. Analyzing the data on Table 2, about
the works mentioned in the last paragraph, the most relevant
work that shows a considerable beneﬁt about alginate’s utiliza-
tion is Krasaekoopt et al. (2004). To explain these differences it
is important to analyze each variable by itself, to understand
where are differences that might explain these results, in differ-
ent works using the same coating. Brinques and Ayub (2011)
and Iyer and Kailasapathy (2005) used the same capsule pro-
ducing technique (extrusion), the same coating method (LBL),
the same concentration of alginate in capsules’ core and in the
coating, and even on Brinques and Ayub’s (2011) work the
same probiotic was used (Lactobacillus acidophilus). Because of
that, the differences in those four works might be justiﬁed by
the differences in capsules’ sizes and in the media used during
in vitro tests. The capsules used by Krasaekoopt et al. (2004)
were signiﬁcantly larger than the ones used in the other works,
which provided a higher surface for coating adhesion and
therefore a higher mass of alginate coating the capsule. This
higher amount of alginate could have had a positive impact on
probiotics protection. Other variable that can justify these dif-
ferences is the type of medium used to simulate the stomach
conditions by Krasaekoopt et al. (2004), who used a smaller
ionic strength compared with the other mentioned works.
Chitosan
Chitin is a natural, linear cationic polysaccharide with glucosamine
andN-acetyl glucosamine residues presented in the shells of crusta-
ceans, molluscs, the cell walls of fungi and the cuticle of insects
(Kumar, 2000). Chitosan has a heterogeneous distribution of acetyl
groups along the chains related with their origin, chitin, that has a
semi crystalline morphology (Rinaudo, 2006). In solution, chitosan
behaves as a cationic polyelectrolyte (Peniche et al., 2003) with
amine residues presents at a pKa around 6.5 and a positive charge
in pH’s below than that (Sogias et al., 2010). Chitosan is insoluble
at pH higher than 5.4, which can be inﬂuenced by the acetylation
degree (Huguet et al., 1996). In Fig. 4 is presented its structure as its
functional groups.
Chitosan obtained from animals is not approved in EU as
food additive but presents the GRAS (Generally Recognized as
Safe) status in USA. However, if obtained from fungi (Aspergil-
lus niger), it is approved for wine processing aid in the Euro-
pean Union (EU, 2012), is GRAS under US FDA regulation
(FDA, 2011) and is approved as food additive in Japan (JFCRF,
2011). Moreover, chitosan obtained from fungi is approved as
additive on the production of wine, beer, cider, spirits and food
grade ethanol by Food Standards by the Australian and New
Zealand legislation (FSANZ, 2013).
One of the problems of using it as the core material in encapsu-
lation is its inhibitory effect against some bacteria (Groboillot et al.,
1993). Nevertheless, due to its cationic behavior and capacity to
resist to acidic media, chitosan is one of the most used materials as
a coating, when considering the utilization of coatings to protect
probiotics against the harsh gastrointestinal conditions.
Cook and co-workers (Cook et al., 2011) evaluated the inﬂu-
ence of a chitosan coating on an probiotic-loaded alginate
microcapsule when exposed to an acidic medium. Results
showed that Biﬁdobacterium breve NCIMB 8807 survived in an
alginate microcapsule with a ﬁnal count of 5.2 § 0.8 log CFU
(from an initial count of 9.5 log CFU), while with the utilization
of a chitosan coating on alginate microcapsules a ﬁnal count of
7.3 § 0.2 log CFU was obtained in the same acidic conditions,
showing an improvement of 2.1§ 1.0 log CFU on bacterial sur-
vival. Authors concluded that chitosan could work as a buffer,
reducing the effect of the acid on bacterial viability, through the
reduction of the microcapsules’ permeability to the acidic
medium, while also maintaining their integrity and thus
decreasing the release of bacteria. Also De Prisco and co-
authors (2015) observed that the utilization of a chitosan
Figure 3. Representation of mannuronic (M) and glucuronic (G) acids that are responsible for alginate’s structure.
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coating improved the survival of Lactobacillus reuteri DSM
17938 on gastric and intestinal media. They showed that there
was no signiﬁcant reduction of the viability of encapsulated
bacteria in coated microcapsules after being subjected to those
media, while for capsules without any coating a reduction of
0.35 log CFU on viable bacteria was observed when subjected
to the acidic medium. Similar ﬁndings were presented by Iyer
and Kalasapathy (2005) when they used a chitosan coating on
alginate microcapsules to protect Lactobacillus acidophilus.
Starting from an initial count of 9.2 log CFU, they obtained a
ﬁnal count of 9.1 log CFU when using chitosan coated micro-
capsules and a ﬁnal count of only 6.3 log CFU for the uncoated
microcapsules (thus a very signiﬁcant 2.8 log CFU difference
between the two). The same results were achieved by other
works using alginate microcapsules coated with chitosan (Dar-
jani et al., 2016; Fareez et al., 2015; Garcıa-Ceja et al., 2015;
Wunwisa Krasaekoopt et al., 2004; Lee et al., 2004; Mi et al.,
2013b; Sohail et al., 2011; Zou et al., 2011).
Other authors also worked with chitosan but no positive
inﬂuence was achieved by the presence of a chitosan coating,
considering Lactobacillus plantarum BL011 protection (Brin-
ques and Ayub, 2011). Graff et al. (2008) used chitosan coating
for the protection of Saccharomyces boulardii, although in this
work there was no evidence of an improvement of the protec-
tive properties of the alginate microcapsule with that material.
Krasaekkopt and Watcharapoka (2014) used chitosan as a coat-
ing for alginate microcapsules and obtained a low performance
considering the protection of Lactobacillus acidophilus and Lac-
tobacillus casei. The initial and ﬁnal viable count have a 6 log
CFU gap which considering the size of the capsules and the
medium used for the gastric simulation, showed a low perfor-
mance when compared with other works.
From the presented works it is clear that the use of a chito-
san coating is one of the means to protect probiotics from gas-
tric conditions and to achieve a controlled delivery in the
intestine. It is also important to mention that some studies do
not show this capacity, although there are no explanations for
these differences. However it is known that biopolymers’ char-
acteristics (i.e., molecular weight, deacetylation degree) and
other experimental conditions have a great inﬂuence on the
behavior of coated microcapsules, and should be considered.
Poly-L-lysine (PLL)
Poly-L-lysine is a cationic natural, non-ribosomal homo-poly
(amino acid), so this nonpeptide is constituted solely by one
type of amino acid in its backbone. This form is naturally
produced by Streptomyces bacteria (Takehara et al., 2008). This
poly(amino acid) is constituted by 25–35 L-lysine residues
(Hamano et al., 2013). Its isoelectric point is approximately 9,
being thus a positively charged material below this pH, mainly
because of its cationic groups such as NH3
C, as presented in
Fig. 5 (Orive et al., 2006; Yoshida and Nagasawa, 2003).
PLL is commercially produced worldwide by a modiﬁed S.
albulus and used as food preservative due to its antimicrobial
activity against a large spectrum of bacteria and fungi (Hamano
et al., 2013); due to its food-grade status it is used as a food
additive in South Korea (Korea and Province, 2014), USA
(FDA, 2003), and Japan (Yoshida and Nagasawa, 2003). This
material has also been used as a layer on delivery systems
applied to medical and pharmacological purposes (Mekhail
et al., 2014; Santos et al., 2012), as well as in probiotic
protection.
PLL’s active properties and charged behavior has led to
the interest to test it as a coating of probiotic-loaded
microcapsules. However, its positive behavior on probiotic
protection is not clear. Cui and co-workers (2000) used a
PLL coating on alginate microcapsules for Biﬁdobacterium
biﬁdus protection and compared their survival in a gastric
ﬂuid simulation medium, showing no statistically signiﬁ-
cant differences between the probiotic survival in coated
and uncoated microcapsules. Also Zou et al. (2011) pre-
sented a comparison between an uncoated alginate micro-
capsule and a PLL-coated alginate microcapsule and did
not observe signiﬁcant differences between the two micro-
capsules regarding the protective behavior toward Biﬁdo-
bacterium biﬁdum F-35 in simulated gastrointestinal tract
media. On the other hand, Iyer and Kalasapathy (2005)
showed that the utilization of PLL as a coating on alginate
microcapsules did have a small relevant positive impact on
bacteria survival, once the ﬁnal counts for surviving bacte-
ria were of 7.3 and 6.3 log CFU for the experiments with
PLL coating and without coating, respectively. In another
work a similar behavior was observed, and the utilization
of PLL and a palm oil mixture as a coating of alginate
microcapsules showed a positive impact on bacteria sur-
vival decreasing by 1 log the bacterial death (B. lactis type
Bl-O4 and B. lactis type Bi-07); however there were other
tested bacteria for which no statistically signiﬁcant differen-
ces were observed between coated and uncoated alginate
microcapsules (Ding and Shah, 2009b).
The apparent contradiction between results reported by differ-
ent authors is rather common in this area. The fact is that often the
works differ in some details which are important. As an example,
Cui and co-workers (2000) used pepsin during the stomach phase
while Iyer and Kalasapathy (2005) did not. This is sufﬁcient to jus-
tify why the ﬁrst group of authors found no statistically signiﬁcant
differences while the second group of authors reported an improve-
ment of 1 log on the survival of probiotics: it is known that pepsin
affects the PLL coating, thus reducing its capacity to protect probi-
otics against the harsh conditions of the gastric medium. In any
case, even when intact, PLL coatings show a rather high porosity
which facilitates the entrance of acidic media and signiﬁcantly
reduces probiotics’ survival in the stomach, thus explaining the
modest improvements of probiotics survival reported by themajor-
ity of the works.
Figure 4. Chitosan structure—positive charges of the amine group are presented.
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Whey protein
Milk proteins (e.g., whey proteins and casein) can be used to
encapsulate probiotics producing a high-density gel network
that can protect probiotic strains. Considering the extreme con-
ditions of stomach, these proteins are able to create a higher
local pH-value within the protein matrix of the capsules, caused
by the proteins’ buffering capacity (Vidhyalakshmi et al., 2009).
Milk proteins have excellent gelation properties and they also
are biocompatible with probiotics (Livney, 2010). More speciﬁ-
cally, whey proteins are often used because of their amphoteric
character, being commonly mixed with negatively charged pol-
ysaccharides such as alginate, carrageenan or pectin. Above
their isoelectric point, these structures change their net charges
to positive, causing an interaction with negatively charged poly-
saccharides (Guerin et al., 2003). Whey proteins usually have
their isoelectric point at pH 5.2 (Ju and Kilara, 1998), at which
aggregation occurs.
Through a coacervation method Gbassi et al. (2009) devel-
oped a whey protein coating for three different types of Lacto-
bacillus plantarum encapsulated in alginate microcapsules.
Positive results were accomplished with the utilization of this
material as a coating, where without the coating there was a
complete inactivation of the bacteria after 90 min. With whey
protein there was a considerable survival at 120 min, in the
range of 5–7 log CFU/g, between the three different bacteria/
experiments. After 180 min of exposure in the simulated intes-
tinal medium a survival ranging between 3 and 4 log CFU/g
was achieved, showing that whey proteins may be used to
enhance bacterial survival in harsh conditions.
However, the use of this kind of coatings is not consensual, and
can be inﬂuenced, e.g., by the microcapsule material. Gebara and
co-workers (2013) performed an experiment with the utilization of
whey protein as a coating for pectin microcapsules. The results
comparing the bacteria survival encapsulated in microcapsules
with and without the whey protein coating did not show statisti-
cally signiﬁcant differences. These tests are difﬁcult to compare
considering that several variables might inﬂuence the results.
Besides the variables listed in each column of Table 2, there are
other factors that may contribute to reduce probiotics’ viability;
these include the physiologic state of probiotics when encapsulated,
the methods used to isolate the capsules after their production and
the methods used to destroy the capsules for viability analyses..
This means that a variety of results using exactly the same proce-
dures and the same probiotic can be expected.
Final remarks on coating materials
Considering alginate as a coating, it is important to mention
that it is not the best material to coat probiotic-loaded micro-
capsules regarding probiotic protection. This is justiﬁed by its
gelling properties and its high porosity, that facilitate perme-
ability (i.e., penetration of the acidic medium) and with this the
contact of probiotics with harsh external conditions. Neverthe-
less, alginate should be used where its properties provide more
relevant advantages, that is, as a microencapsulation material.
As well as alginate, PLL was used in some works and showed
that it does not have a strong capacity to be used as a microcap-
sule coating for probiotics protection against harsh media. Due
to its strong capacity to interact with alginate microcapsules,
because of its positively charged state above pH 9, PLL utiliza-
tion brings a potential functionality for LbL assembly. It would
thus be interesting to perform further studies in order to under-
stand PLL’s capacity to provide other functions to the coated
microcapsules.
Chitosan showed to be the most interesting material to pro-
tect microencapsulated probiotics, with good results in different
alginate microcapsules (produced by different techniques and
with different types of alginate), probiotics strains and environ-
mental conditions. It is also important to notice that in all pre-
sented works the core was mainly constituted by alginate.
Considering the different techniques used to coat microcap-
sules it is interesting to notice that alginate is used in most cases
as a second microcapsule and not as a coating. On the contrary,
chitosan and PLL, both positively charged compounds, are
almost always used as a coating by LbL assembly, while whey
proteins are in all cases used as a coating by complex coacerva-
tion. Comparing the two main coating methodologies it is pos-
sible to conclude that the more important factor is the type of
material used (excellent results on probiotic protection by chi-
tosan and not so positive with PLL).
Table 2 clearly shows that it is extremely difﬁcult to compare
results from different works, mainly when so many variables
might inﬂuence them. However, within the same work, com-
parisons are possible and were presented in Table 2 (Brinques
and Ayub, 2011; Iyer and Kailasapathy, 2005; Krasaekoopt
et al., 2004; Martoni et al., 2007; Zou et al., 2011). It is impor-
tant to mention that when the performance of a given material
is reported as being good or bad, it does not mean that it would
be the same under different conditions/applications. Thus the
main conclusion here is that each material may have potential
and it is important to analyze the combination of materials,
techniques and tests performed in a case-by-case basis.
Microcapsules with two or more coatings
Some works also report the utilization of more than one coat-
ing, in order to improve probiotics survival during the passage
by the gastrointestinal harsh conditions. The adhesion of a sec-
ond coating is only possible by subsequent microencapsulation
or through the utilization of the LbL assembly technique.
The protection capacity of PLL and alginate (ﬁrst and sec-
ond coating, respectively) was compared with a unique alginate
coating (Krasaekoopt et al., 2004) in alginate microcapsules.
On the three bacteria studied (Lactobacillus acidophilus 547,
Biﬁdobacterium biﬁdum ATCC 1994, and L. casei 01) the
Figure 5. Poly-L-lysine chemical structure and its charged amine group.
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system that always presented better protection of the bacteria
was the one with only one coating of alginate (with an
increased survival between 1 and 3 log CFU, depending on the
bacteria tested). However, the alginate/PLL/alginate (APA) sys-
tem showed a better performance than the uncoated microcap-
sules. Results showed that the utilization of the APA system for
L. acidophilus and L. casei allowed an increase of survival of 4
log CFU and 1 log CFU, respectively, and for B. biﬁdum no sig-
niﬁcant differences were observed. In another work where an
APA system was used to protect L. plantarum, results showed
an increasing survival of 6 log CFU (with a starting count of 10
log CFU) when compared with the uncoated L. plantarum-
loaded microcapsules. However, there are no results consider-
ing the uncoated system, or even the system with just a single
coating, thus making it impossible to compare these results
with previous works (Martoni et al., 2007).
The results discussed before were similar on, the single and
double coating showed an increase of the protective effect com-
pared with the uncoated microcapsule on the gastric simulation
(1 and 3 log increase on survival), although on the intestinal
tests just the double coating made a difference (1 and 2 log
increase on survival). Comparing the results of microcapsules
coated with one and two coatings it is possible to understand
that the microcapsules with two coatings presented a better
performance on the acidic environment than the monocoated
microcapsules.
In conclusion there is no evidence that a higher number of
coatings could perform a better protection when compared
with microcapsules with a single coating, but more works with
more than a single coating are needed to clarify this issue.
Conclusions and future perspectives in probiotic
encapsulation
Without any doubt one of the research trends in this area is to
ﬁnd industrial encapsulation technologies that guarantee the
survival of probiotics.
When considering the issues mentioned before about cells
survival in spray drying encapsulation technique, due to over-
heating, spray chilling appears as one of the alternatives for
probiotic encapsulation. Spray chilling has the same approach
as spray drying but using a cold conveying air cold chamber,
instead of hot air (Champagne and Fustier, 2007; Pedroso et al.,
2012). Electrodynamic processes, such as electrospraying and
electrospinning, can be also used for the encapsulation of pro-
biotics. The main advantages of these techniques are their
capacity to create very thin ﬁbers or capsules that could be
obtained in different scales. These techniques start to be used
in the food area, namely on packaging materials and encapsula-
tion of bioactive compounds, and more recently also for probi-
otics microencapsulation (Laelorspoen et al., 2014; Lopez-
Rubio et al., 2012).
Considering the materials used in microencapsulation, a
major concern has been the utilization of food grade ingre-
dients and in some cases food itself as the main material for
encapsulation. Some examples are the utilization of goat’s milk
(Ranadheera et al., 2015), pea protein (Kent and Doherty,
2014), peanut butter (Klu and Chen, 2015) and chocolate
(Champagne et al., 2015; Kemsawasd et al., 2016). The
utilization of food ingredients as the main material of a micro-
capsule could be an interesting way of creating a more natural
core shell, from a consumer’s point of view, and a more homo-
geneous food product. Something similar is happening but
with the utilization of prebiotics as the main microcapsule
material instead of encapsulating them together with probiot-
ics. Some examples are the use of fructooligosacharides (Rajam
and Anandharamakrishnan, 2015), native rice starch and inulin
(Avila-Reyes et al., 2014). The utilization of new materials can
also improve the performance of conventional systems, being
the utilization of new sources of natural ingredients very
important to the development of this area.
Innovation on probiotics microencapsulation has been
achieved not only through the development of new indus-
trial/laboratorial equipment but also by the utilization of
methodologies/technologies used in other ﬁelds of knowl-
edge. There are also other important perspectives in the utili-
zation of probiotic microcapsules, e.g., in some cases
microcapsules are used as a continuous microreactor able to
be a continuous producer of micronutrients in the human
gut (Ramos et al., 2016).
The actual trend is to focus on precision and customization
in food production. Thus, food processing in general, and spe-
ciﬁcally microencapsulation, is evolving to the utilization of
state-of-the art technologies such electrospinning or even 3D
printing, pointing at the need to maintain research efforts in
this attractive and promising area of knowledge.
However, more research efforts are needed in order to
address the capacity of some materials for probiotics protec-
tion. More than that, a standardization of the gastrointestinal
simulation procedures would be very important to compare
and conclude which materials and techniques could suit better
the needs of each probiotic and food system.
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